McKenzie Jo-Lyn, Douglas Genevieve, Bazargan Ali
Department of Surgery, St Vincent's Hospital, Melbourne, Victoria, Australia.
ANZ J Surg. 2013 Nov;83(11):814-20. doi: 10.1111/ans.12171. Epub 2013 Apr 18.
Surgeons commonly need to treat patients receiving anticoagulant and anti-platelet therapy. This requires risk assessment and management to balance minimization of bleeding complications and avoidance of further ischaemic or thrombotic events. This review considers the evidence available to guide management of patients on anti-platelet and anticoagulant therapy, including some of the new classes of anti-platelets and anticoagulants which clinicians may be less familiar with.
外科医生常常需要治疗正在接受抗凝和抗血小板治疗的患者。这需要进行风险评估和管理，以平衡将出血并发症降至最低与避免进一步的缺血或血栓形成事件。本综述探讨了可用于指导抗血小板和抗凝治疗患者管理的现有证据，包括一些临床医生可能不太熟悉的新型抗血小板和抗凝药物。
